Deep Brain Stimulation Device Market Analysis, Scope And Outlook 2025 - 2034

Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

How Is the Deep Brain Stimulation Device Market Expected to Expand in Terms of Size and Growth?
The deep brain stimulation device market size has grown rapidly in recent years. It will grow from $1.54 billion in 2024 to $1.7 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increased prevalence of neurological disorders, aging population, limited efficacy of medications, increased awareness and acceptance, improved surgical techniques.

The deep brain stimulation device market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to expanding indications for dbs, rising healthcare expenditure, development of next-generation devices, increasing patient acceptance, government initiatives and funding, collaborations and partnerships. Major trends in the forecast period include patient-centric design and user interface, research and development in closed-loop neuromodulation, telehealth integration, regulatory pathway clarifications, increased collaboration and partnerships.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10733&type=smp

What Are the Most Significant Drivers Affecting the Deep Brain Stimulation Device Market Expansion?
The increasing prevalence of neurological diseases is expected to propel the growth of the deep brain stimulation device market going forward. Medical conditions affecting the central and peripheral nervous systems are known as neurological disorders. Deep brain stimulation devices are used to control abnormal brain activity and adjust the chemical imbalances within the brain that cause various conditions. For instance, in February 2023, according to the World Health Organization, a Switzerland-based specialized health agency, around 50 million people globally had epilepsy. Moreover, in 2022 according to the Parkinson’s Foundation report, a US-based non-profit organization working for Parkinson’s disease patients, the new diagnosis of Parkinson’s disease reached 90,000 per year. This is a 50% increase from the previously expected rate of 60,000 diagnoses per year. As a result, the increasing prevalence of neurological disorders is propelling the growth of the deep brain stimulation device market.

Which Segment Holds the Largest Share in the Deep Brain Stimulation Device Market?
The deep brain stimulation devicemarket covered in this report is segmented –

1) By Product Type: Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator
2) By Application: Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Pain Management, Other Applications
3) By End User: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers

Subsegments:
1) By Single-Channel Deep Brain Stimulator: Implantable Pulse Generators, Electrode Leads, Accessories
2) By Dual-Channel Deep Brain Stimulator: Implantable Pulse Generators, Electrode Leads, Accessories

How Are Innovation and Technology Shaping the Future Trends of the Deep Brain Stimulation Device Market?
Major companies operating in the deep brain stimulation device market are developing technological advancements, such as connected care technology, to enhance patient care by enabling remote programming, improving communication between patients and healthcare providers, and optimizing treatment outcomes for individuals with movement disorders. Connected care technology refers to the integration of digital tools and platforms that facilitate continuous communication and data exchange between patients and healthcare providers, enhancing patient monitoring, treatment management, and overall healthcare delivery. For instance, in January 2024, Abbott Laboratories, a US-based healthcare and medical device company, received US Food and Drug Administration approval for the Liberta RC DBS system, the smallest rechargeable deep brain stimulation device for treating movement disorders. Key features of the Liberta RC DBS system include remote programming via the NeuroSphere Virtual Clinic, a requirement of only 10 recharges per year, and a compact design that is 31% smaller than competing devices. It also boasts a wireless charging system that can recharge the device every 37 days and offers customizable controls through an Abbott patient controller or compatible iOS devices.

Which Companies Are Driving Innovation in the Deep Brain Stimulation Device Market?
Major companies operating in the deep brain stimulation device market include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation Ltd, NeuroPace, Inc., LivaNova PLC, Beijing PINS Medical Co. Ltd., SceneRay Corporation, Synapse Biomedical Inc., Deep Brain Innovation LLC, Nevro Corp., MicroPort NeuroTech, Stimwave LLC, Sapiens Neuro, Neuronetics Inc., BlueWind Medical Ltd., Brainsway Ltd., Neuralink Corporation, Med-Ally LLC, Axion BioSystems Inc., CereGate GmbH, NeuroSigma Inc., Bioinduction Ltd., Alpha Omega Engineering Ltd., Helius Medical Technologies, ANM Adaptive Neuromodulation GmbH, MagVenture A/S, Precisis AG, Monteris Medical Inc.

Get the full deep brain stimulation device market report here:
https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-device-global-market-report

How Is the Competitive Landscape Varying Across Different Regions in the Deep Brain Stimulation Device Market?
North America was the largest region in the deep brain stimulation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep brain stimulation devices market report during the forecast period. The regions covered in the deep brain stimulation device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company